This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

News Articlesrss feed

England world leaders in the use of Whole Genome Sequencing to diagnose TB

In a world-first, Whole Genome Sequencing (WGS) is now being used to identify different strains of tuberculosis, announced Public Health England today. This is the first time that WGS has been used as a diagnostic solution for managing a disease on this scale anywhere in the world. This builds on WGS based services for public […]

New trial for blindness rewrites the genetic code

Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people. Retinitis pigmentosa is currently untreatable and leads to a slow and irreversible loss of vision. For the full story on Oxford Biomedical Research Centre website  

Oxford Health named as Global Digital Exemplar

Oxford Health NHS Foundation Trust is to spearhead the development of digital technology in mental healthcare nationally, thanks to £5m funding. The trust is one of just seven NHS trusts delivering mental healthcare nationally to be named as a Global Digital Exemplar for its innovative use of technology to care for people who use mental […]

Oxford School of Nursing and Midwifery announced

A new Oxford School of Nursing and Midwifery has been launched in March 2017, through a unique partnership between Oxford Brookes University, Oxford University Hospitals NHS Foundation Trust and Oxford Health NHS Foundation Trust, under the umbrella of the Oxford Academic Health Science Centre (OxAHSC). It has been developed in response to a unique period […]

Genetic sequencing offers same-day TB testing

Researchers have for the first time shown that standard tuberculosis (TB) diagnostic tests can be replaced by a sub-24 hour genetic test applied to the TB bacteria in a patient’s sputum. For the full story on University of Oxford website

Study offers hope of new treatment for rheumatoid arthritis

Patients who do not respond to current rheumatoid arthritis (RA) treatments may benefit from a new form of treatment that has been shown in a study to be effective against symptoms of the disease. The RA-BEAM study is the first to demonstrate that the drug baricitinib is more effective in improving the symptoms of rheumatoid […]

New £100 million Rosalind Franklin research institute to improve health through physical science innovation

Oxford University scientists are to play a key role in a new, government-funded research facility, the Rosalind Franklin Institute (RFI). Backed by over £100 million of investment, the RFI will be a national centre of excellence in technology development and innovation. Physical scientists, engineers and life scientists will work together to develop new techniques and […]

Oxford University expands evidence-based methods courses for health care professionals

Oxford University is launching two new Masters’ degrees in Evidence Based Health Care as part of its continuing professional development programme to enable health care professionals worldwide to base their clinical decisions on valid, reliable and relevant evidence. The two new courses focus specifically on medical statistics and systematic reviews within the wider context of […]

Drugs from bugs tops list of LAB282’s first round of grants

LAB282, the £13m drug discovery partnership for Oxford University, has made its first wave of awards, backing projects targeting cardiovascular and infectious diseases. Launched last year as a partnership between the University, Evotec and Oxford Sciences Innovation, LAB282 aids the rapid translation of research outputs into new drug discovery and development programmes. It draws on […]